6 min read

Stock Market News — May 12, 2026 - Morning update, Pacific Time

U.S. stocks fell Tuesday as hotter-than-expected April CPI data and Iran ceasefire stalling cooled the AI rally, while eBay flatly rejected GameStop's $56 billion takeover bid. JPMorgan's Jamie Dimon warned of "too much exuberance" as European markets closed broadly lower and ZoomInfo crashed 35% on

Executive Summary

U.S. equities fell Tuesday as hotter-than-expected April CPI data collided with a stalling Iran ceasefire, pushing oil higher and cooling the AI-driven rally that dominated last week. The GameStop-eBay saga took a dramatic turn as eBay flatly rejected GME's audacious $56 billion takeover bid, calling it "neither credible nor attractive." Meanwhile, European markets closed broadly lower, and JPMorgan's Jamie Dimon added a sobering note by warning of "a little too much exuberance" in markets.


Sentiment Breakdown

Sentiment Count Percentage
🟢 Bullish 68 33%
🟡 Neutral 42 21%
🔴 Bearish 95 46%

Net Sentiment: Bearish — Inflation surprise, Middle East stalemate, and broad European/Asian selloffs outweigh isolated stock-specific rallies.


Top Market-Moving Headlines

🔴 Macro | Stocks fall as hot April consumer inflation data, Iran impasse weighs on sentiment
Market Impact: Hotter-than-expected CPI killed rate-cut hopes and triggered broad selling in equities. The Iran ceasefire described as "on life support" added an oil-supply risk premium.

🔴 M&A | eBay rejects GameStop's $56 billion bid as 'neither credible nor attractive'
Market Impact: eBay's board dismissed GME's unsolicited $125/share offer, citing financing doubts. The rejection sends GameStop's crypto-treasury-fueled dealmaking ambitions back to square one.

🟢 Consumer | Wendy's stock surges +15% on report of potential Trian buyout bid
Market Impact: Nelson Peltz's Trian Fund is reportedly seeking investor backing for a take-private of Wendy's, sparking the biggest single-day move in the fast-food chain in years.

🔴 Healthcare | Hims & Hers plunges 11-14% as branded weight-loss drug pivot hits results
Market Impact: The telehealth company missed Q1 revenue estimates as its strategic shift away from compounded GLP-1 drugs toward branded alternatives crushed near-term sales.

🟢 Entertainment | Netflix stock rallies nearly 4% on sweeping new initiative
Market Impact: Netflix launched a major new content or monetization initiative (details undisclosed), reigniting investor confidence and pushing shares sharply higher mid-session.

🔴 Tech/Semis | AMD stock slides nearly 5% on sector-specific regulatory headwinds
Market Impact: Sector rotation out of chip stocks, compounded by regulatory pressures, hit AMD hard — part of a broader AI-rally cooldown following last week's surge.

🟢 Enterprise Tech | Zebra Technologies surges ~18% on earnings
Market Impact: The enterprise data-capture company delivered a blowout quarter, making it one of the session's biggest large-cap winners and a bright spot in an otherwise weak tape.

🔴 Tech/SaaS | ZoomInfo Technologies stock crashes 35% after steep after-hours selloff
Market Impact: A severe earnings miss triggered one of the day's worst single-stock collapses, wiping out significant market cap and raising questions about B2B software demand.

🟢 Pharma | Vertex Pharmaceuticals rises 3.63% to $450.96
Market Impact: Continued investor rotation into defensive healthcare names with strong pipelines; Vertex benefited from positive sentiment around its cystic fibrosis franchise.

🟢 Tobacco/Consumer | Philip Morris International gains +3.26% after FDA guidance
Market Impact: The FDA issued guidance signaling a favorable regulatory environment for PMI's smoke-free products, validating the company's long-term pivot away from cigarettes.

🔴 Nuclear/Energy | Oklo stock slides 8.51% as investors rotate out
Market Impact: Profit-taking and sector rotation hit the advanced nuclear developer hard, reversing some of the AI-energy enthusiasm that had driven shares higher in recent weeks.

🔴 Apparel | Under Armour slides ~14% on another weak annual forecast
Market Impact: UAA guided for another year of revenue decline and below-consensus profit, with North America continuing to struggle — a stark contrast to rival On Holding's raised guidance.

🟢 Sportswear | On Holding raises 2026 profit margin forecast — the 'Zendaya effect'
Market Impact: The Swiss sportswear brand credited celebrity partnerships and strong brand momentum for lifting its margin outlook, reinforcing its position as a premium-growth story.

🟢 AI/Cybersecurity | Pentagon deploys Anthropic's Mythos; U.S. banks rush to use it
Market Impact: Anthropic's new cybersecurity model is being adopted simultaneously by the Pentagon and major U.S. banks to patch software vulnerabilities — a landmark dual-sector AI deployment.

🟢 Aerospace | Boeing's new order bookings surge in April — 135 net new orders
Market Impact: Boeing nearly matched its entire Q1 order total in a single month, signaling a meaningful recovery in commercial aviation demand and easing production-ramp concerns.

🔴 Semis/AI Tax | AI tax scare wipes out $300B: Samsung, Nvidia, and chip stocks fall
Market Impact: South Korean policymakers proposed a "citizen dividend" funded by AI companies, triggering a global chip selloff and erasing roughly $300 billion in sector market cap.

🟢 Space/Tech | Google in talks with SpaceX for rocket launch deal
Market Impact: Alphabet's reported discussions with SpaceX signal an aggressive push to expand satellite infrastructure, with implications for cloud computing and connectivity competition.

🟡 AI/Investment | Goldman Sachs: Non-hardware AI investments could exceed $1 trillion globally
Market Impact: Goldman's forecast underscores the scale of the AI buildout ahead, with software, agents, and services set to dwarf hardware spending — a key sector rotation signal.

🟡 Macro/Fed | Morgan Stanley expects the Fed to maintain a wait-and-see approach
Market Impact: Core CPI rose 0.38% MoM in April per Morgan Stanley's analysis, reinforcing that the Fed has no near-term catalyst to cut rates — keeping pressure on rate-sensitive equities.

🟢 Biotech/Pharma | Novo Nordisk's Wegovy shows 21% weight loss regardless of response speed
Market Impact: New STEP UP trial data presented at the European Congress on Obesity strengthens Wegovy's clinical profile and supports Novo's dominant position in the GLP-1 market.


Market Implications

Inflation + Iran = A Tough Setup for Bulls. The hotter April CPI print has effectively pushed Fed rate-cut expectations further out, while the Iran ceasefire collapsing "on life support" keeps oil elevated and supply-chain uncertainty alive. This combination is particularly damaging for growth and rate-sensitive sectors — tech, real estate, and consumer discretionary. Jefferies has already raised its 2026 commodity inflation forecast by 90 basis points to 2.1% YoY, suggesting the pressure isn't transitory.

AI Enthusiasm Is Real, But Fragile. The $300 billion chip selloff triggered by South Korea's proposed AI tax is a reminder that regulatory risk is now a genuine overhang for the sector. Goldman's $1 trillion non-hardware AI investment forecast and the Pentagon/banking adoption of Anthropic's Mythos confirm the structural trend is intact — but investors should expect more volatility as governments worldwide eye AI revenues. The AMD slide and Oklo rotation suggest the easy money in the AI trade may already be made.

M&A and Earnings Divergence Creating Opportunities. The GameStop-eBay rejection, Wendy's buyout speculation, EQT's Volkswagen marine unit bid, and Intertek's £9.4 billion takeover offer all point to an active deal environment despite macro headwinds. Meanwhile, earnings divergence is sharp: Zebra Technologies (+18%) and On Holding (raised guidance) vs. Under Armour (-14%) and ZoomInfo (-35%) suggest stock-picking is back in style. Watch next week's Home Depot, Cava, and Toll Brothers reports for consumer health signals.


Key Takeaways

  • 🔴 CPI (April) — Hotter-than-expected print kills near-term rate-cut hopes; Fed stays on hold per Morgan Stanley.
  • 🔴 Iran Ceasefire — Talks described as "on life support," keeping oil elevated and risk sentiment suppressed.
  • 🔴 $GME / $EBAY — eBay rejected GameStop's $56B bid as "neither credible nor attractive"; deal is dead for now.
  • 🟢 $WEN — Wendy's surges 15%+ on Trian Fund take-private speculation; watch for formal bid.
  • 🔴 $HIMS — Hims & Hers falls 11-14% as GLP-1 strategy pivot crushes Q1 revenue; guidance disappoints.
  • 🟢 $ZBRA — Zebra Technologies surges ~18% on blowout earnings; enterprise hardware demand alive.
  • 🔴 $ZI — ZoomInfo crashes 35% on severe earnings miss; B2B software demand under scrutiny.
  • 🔴 $AMD — AMD falls ~5% on regulatory headwinds and sector rotation out of chips.
  • 🟢 $NFLX — Netflix rallies ~4% on major new initiative; also disclosed $135B+ spent on content over last decade.
  • 🟢 $PM — Philip Morris gains 3.26% after FDA guidance favors smoke-free products.
  • 🔴 $UA — Under Armour slides ~14%; guides for another year of revenue decline in North America.
  • 🟢 On Holding — Raises 2026 profit margin forecast; "Zendaya effect" driving brand momentum.
  • 🟢 Anthropic/Mythos — Pentagon and U.S. banks simultaneously deploying Mythos cybersecurity AI; major adoption signal.
  • 🔴 Chip Sector — South Korea's proposed AI "citizen dividend" tax triggers $300B global chip selloff.
  • 🟢 Boeing — 135 net new orders in April nearly matches entire Q1 total; recovery gaining traction.
  • 🟢 Goldman Sachs — Non-hardware AI investments forecast to exceed $1 trillion globally; software/agents are the next wave.
  • 🟡 Jamie Dimon — JPMorgan CEO warns of "a little too much exuberance" in markets amid global tensions.
  • 🟢 Novo Nordisk — Wegovy shows 21% weight loss in new STEP UP data; GLP-1 dominance reinforced.
  • 🟡 Google/SpaceX — Alphabet in talks with SpaceX for rocket launch deal; satellite infrastructure race intensifies.
  • 🔴 European Markets — DAX -1.54%, AEX -1.55%, IBEX -1.56%, Turkey -2.34%; broad selloff driven by Iran/inflation fears.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/